In recent months, pharmaceutical chain sources have struggled to find the right answer to flatten the Covid-19 infection curve. Come on – once vaccines are able to be delivered What’s essential now is to prepare a war room to administer the distribution procedure to help pharmaceutical corporations design better responses for a more connected and physically powerful supply chain.
As medicines and vaccines move toward definitive clinical trials in the fight against the Covid-19 pandemic, pharmaceutical corporations are rushing to build solid source chains for safe delivery. long-term vaccines in unprecedented quantities around the world, the air transport industry is moving towards its distribution process.
The distribution cycle is complex: move drugs/vaccines in environmental situations from high-sea production sites to final delivery locations with various problems in the chain of origin along the way, whether garage farms, shipping terminals, airplanes, warehouses, keep all this in mind. It’ll be over in a matter of days. Goliath’s task will also face more demanding situations, such as cooling unit failures, temperature variations, damaged packaging, and other incidents that can disable thousands of vials.
“The pharmaceutical industry does not yet know which of the progressive vaccines will succeed in the final line and will be approved by the fitness authorities. Therefore, to date, we are unaware of the characteristics of long-term vaccines: 1, 2 or 3 injections. Industry readiness would also require an explanation of chain-of-origin requirements, the addition of production sites, rapid management and garage conditions, and real-time tracking requirements,” said Céline Hourcade, ITACA’s transition director, when asked about preparing the industry to manage mass shipment of vaccines and medicines.
He’s getting together.
For industry players, who in the past have painted in silos, it will be imperative to paint in combination to achieve some end-to-end visibility. Lack of end-to-end visibility will have a negative effect on players in the price chain. “We believe that other organizations are essential for the good fortune of pharmaceutical air standardization and end-to-end visibility, beyond the distribution of COVID-19 vaccines: IATA, FIATA, ACI, local air shipping associations, ULDCARE, Cool Chain Association (CCA), as well as fitness organizations such as WHO, GAVI Alliance, UNICEF,” he said.
But partnerships and public-private relations actually took Covid-19 a step forward, notes Vijan Chetty, a member of the Cool Chain Association. “Organizations have also taken a step forward in their agility and will reorganize their business models to ensure mass shipment of vaccines. “”The CCA is confident that there will be smart cooperation and collaboration among all organizations to ensure that vaccines are distributed around the world. “
Logistics and airlines are being prepared
“In fact, it will be a historic achievement of the chain of sources to distribute millions, if not billions, of life-saving Covid-19 vaccine vials to giant global populations,” said Wes Wheeler, president of UPS Healthcare. “Lives will count on it, that we succeed in these vaccine deployments, and we are well prepared to assist in all those efforts until this pandemic is us. “
Recently, Air France KLM Martinair Cargo (AFKLMP Cargo) formed a functioning organization to outline the critical steps needed to send Covid-19 vaccines. In close consultation with the pharmaceutical industry and related carriers, the airline assessed the express needs for the shipment of Covid -19 vaccines, adapting its operation in terms of compromised equipment and monitoring and service, as well as the capacity it offers. Enrica Calonghi, global head of pharmaceutical logistics at AFKLMP Cargo, said: “The shipment of vaccines is not new to the air shipping industry: Air France KLM Martinair Cargo has been sending general influenza vaccines for years, however, the expected number of vaccines to be shipped and the short time required to do so are the two differentiating points in the distribution of Covid-19 vaccines. “
“This transport, to some extent, is a repetition to make sure we are well prepared for the Covid-19 vaccine once your tests are complete,” said Yulia Celetaria, Global Pharmaceuticals Director at AirBridgeCargo Airlines. “Over the past five years, we have deepened our cooperation with suppliers of temperature sensitive boxes and now, in the midst of the pandemic, we are in constant conversation with our trusted partners, Envirotainer, SkyCell, va-Q-tec, DoKaSch, CSafe, Sonoco and others related to strategic container reservation.
Understand the optimal conditions of the vaccine garage
While the ideal situation would be to have a single injectable vaccine insensitive to the bloodless chain, Covid-19 vaccines will likely want to be maintained between 2 and 8 degrees Celsius during the sending procedure or even those requiring freezing (minus 80 degrees Celsius), any discrepancies can ruin the shots. The single or multidose dose technique, sensitive without blood, sensitive without blood or frozen will have other effects on the chain of origin, so the faster the logistics sector is aware of what is coming, the greater it will be able to plan and adapt its capacity.
Recognizing the need for secure temperature controlled air shipping solutions, Envirotainer, which has expanded its sales offering in Asia Pacific in recent years, has invested in service functions and an agile network model. Recently added Beijing (PEK), China to its development. list of network stations; This station will bring the RKN e1 and RAP e2 boxes and provide a significant increase in the capacity of China’s developing pharmaceutical export market. The new station will be operational from September 1.
“Going forward, there are many uncertainties related to Covid-19 vaccine shipments. Array” As an industry, we want to make sure we have a strong temperature controlled air shipment source chain to make sure vaccines are delivered in a safe, “said Eddy Cojulun. , Envirotainer sales manager. He continues:” Once a vaccine is available, we know that it will require temperature controlled air shipment and very large global distribution. We hope that our investment in the Beijing hotel will contribute to a faster and safer delivery of Covid-19 vaccines to others who want them, anywhere in the world.
Drones for vaccine administration
At the recent Cargo Drones virtual summit hosted through STAT Media Group, Angela Yochem, executive vice president and chief technology officer of Novant Health, based in the US, said she was a member of the United States. The U. S. lobbied for the desire for health care corporations to compare new modes of transportation such as drones, especially in very fluid conditions. as a pandemic outbreak, where the need for materials is unpredictable. Novant Health is currently using drones, in partnership with Zipline, to distribute its essential medical products to hospitals in your region. For Novant Health, which operates 15 hospitals and nearly 700 sites in the southeastern United States, the operation can become a game. Changes in uses such as testing, drug testing and vaccine distribution, especially as the Covid-19 pandemic. continues to develop.
Interestingly, at an earlier webinar, Parag Deshmukh, Additional Director of Global Strategic Business Development, Serum Institute of India, spoke about the prospective use of drones for covid-19 vaccine administration in highly populated and remote locations in India. Institute of India partnered with AstraZeneca, a British biopharmaceutical giant, to manufacture Covid-19 vaccines, which are recently being tested at Oxford University. “For all these vaccines, the actual burden is only 30-40%, while the delivery load requires This is a specific challenge when affordability will be a major fear for many countries regarding the Covid-19 vaccine. It will be a huge task for logistics actors. Be prepared with your talent for taking care of this. We’ll want a bloodless chain whose temperature is controlled between 2 and 8 degrees Celsius,” he added.
What is essential now is to prepare a war room to manage the distribution procedure for pharmaceutical corporations to design greater responses for a more connected and physically powerful source chain.
What is essential now is to prepare a war room to manage the distribution procedure for pharmaceutical corporations to design greater responses for a more connected and physically powerful source chain.